These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 1719712)

  • 1. [Synthesis and anti-retroviral activity of various new 2',3'-dideoxynucleoside analogs].
    Van Aerschot A
    Verh K Acad Geneeskd Belg; 1991; 53(4):387-418. PubMed ID: 1719712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 4'-C-ethynyl-2',3'-dideoxynucleoside analogue highlights the role of the 3'-OH in anti-HIV active 4'-C-ethynyl-2'-deoxy nucleosides.
    Siddiqui MA; Hughes SH; Boyer PL; Mitsuya H; Van QN; George C; Sarafinanos SG; Marquez VE
    J Med Chem; 2004 Oct; 47(21):5041-8. PubMed ID: 15456247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of 2',3'-didehydro-2',3'- dideoxy-5-fluorocytidine (D4FC) analogues: discovery of carbocyclic nucleoside triphosphates with potent inhibitory activity against HIV-1 reverse transcriptase.
    Shi J; McAtee JJ; Schlueter Wirtz S; Tharnish P; Juodawlkis A; Liotta DC; Schinazi RF
    J Med Chem; 1999 Mar; 42(5):859-67. PubMed ID: 10072683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of 3'-azido-3'-deoxynucleosides on the reproduction of AIDS virus in cell culture].
    Galegov GA; Korneeva MN; Nosik DN; Kilesso TIu; Kraevskiĭ AA
    Mol Biol (Mosk); 1988; 22(3):802-6. PubMed ID: 2460737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New nucleoside reverse transcriptase inhibitors for the treatment of HIV infections.
    Otto MJ
    Curr Opin Pharmacol; 2004 Oct; 4(5):431-6. PubMed ID: 15351346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Halogeno-3'-fluoro-2',3'-dideoxyuridines as inhibitors of human immunodeficiency virus (HIV): potent and selective anti-HIV activity of 3'-fluoro-2',3'-dideoxy-5-chlorouridine.
    Balzarini J; Van Aerschot A; Pauwels R; Baba M; Schols D; Herdewijn P; De Clercq E
    Mol Pharmacol; 1989 May; 35(5):571-7. PubMed ID: 2725468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives for the chemotherapy of AIDS.
    De Clercq E
    Anticancer Res; 1987; 7(5B):1023-38. PubMed ID: 3324934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enantiomeric 2',3'-dideoxycytidine derivatives are potent human immunodeficiency virus inhibitors in cell cultures.
    Gosselin G; Mathé C; Bergogne MC; Aubertin AM; Kirn A; Schinazi RF; Sommadossi JP; Imbach JL
    C R Acad Sci III; 1994 Jan; 317(1):85-9. PubMed ID: 7987696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased anti-human immunodeficiency virus type-1 activities of 2',3'-dideoxynucleoside analogs in MOLT-4 cell sublines resistant to 2',3'-dideoxynucleoside analogs.
    Cinatl J; Cinatl J; Weber B; Rabenau H; Weissflog A; Mainke M; Kornhuber B; Doerr HW
    Acta Virol; 1993 Oct; 37(5):360-8. PubMed ID: 8184788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incorporation of nucleoside analogs by human immunodeficiency virus type 1 reverse transcriptase decreases in the presence of polyamines.
    Bakhanashvili M; Rahav G
    FEBS Lett; 2006 Oct; 580(22):5363-70. PubMed ID: 16989821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and anti-HIV-1 activity of 2'-"up"-fluoro analogues of active anti-AIDS nucleosides 3'-azido-3'-deoxythymidine (AZT) and 2',3'-dideoxycytidine (DDC).
    Watanabe KA; Harada K; Zeidler J; Matulic-Adamic J; Takahashi K; Ren WY; Cheng LC; Fox JJ; Chou TC; Zhu QY
    J Med Chem; 1990 Aug; 33(8):2145-50. PubMed ID: 1695683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors determining the activity of 2',3'-dideoxynucleosides in suppressing human immunodeficiency virus in vitro.
    Hao Z; Cooney DA; Hartman NR; Perno CF; Fridland A; DeVico AL; Sarngadharan MG; Broder S; Johns DG
    Mol Pharmacol; 1988 Oct; 34(4):431-5. PubMed ID: 2459590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3'-Fluoro-2',3'-dideoxy-5-chlorouridine: most selective anti-HIV-1 agent among a series of new 2'- and 3'-fluorinated 2',3'-dideoxynucleoside analogues.
    Van Aerschot A; Herdewijn P; Balzarini J; Pauwels R; De Clercq E
    J Med Chem; 1989 Aug; 32(8):1743-9. PubMed ID: 2754700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemistry and anti-HIV properties of 2'-fluoro-2',3'-dideoxyarabinofuranosylpyrimidines.
    Siddiqui MA; Driscoll JS; Marquez VE; Roth JS; Shirasaka T; Mitsuya H; Barchi JJ; Kelley JA
    J Med Chem; 1992 Jun; 35(12):2195-201. PubMed ID: 1351945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of new potent and selective agents against HIV (human immunodeficiency virus).
    Pauwels R; Schols D
    Verh K Acad Geneeskd Belg; 1991; 53(6):629-55. PubMed ID: 1816706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and anti-HIV evaluation of 2',3'-dideoxyribo-5-chloropyrimidine analogues: reduced toxicity of 5-chlorinated 2',3'-dideoxynucleosides.
    Van Aerschot A; Everaert D; Balzarini J; Augustyns K; Jie L; Janssen G; Peeters O; Blaton N; De Ranter C; De Clercq E
    J Med Chem; 1990 Jun; 33(6):1833-9. PubMed ID: 2342078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of nucleoside analogs on neurite regeneration and mitochondrial DNA synthesis in PC-12 cells.
    Cui L; Locatelli L; Xie MY; Sommadossi JP
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1228-34. PubMed ID: 9067308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluoro-CTP with human immunodeficiency virus-1 reverse transcriptase and human DNA polymerases: implications for human immunodeficiency virus drug design.
    Kukhanova M; Li X; Chen SH; King I; Doyle T; Prusoff W; Cheng YC
    Mol Pharmacol; 1998 May; 53(5):801-7. PubMed ID: 9584205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of 2',3'-dideoxycytidine diphosphocholine and 2',3'-dideoxycytidine diphosphoethanolamine. Prominent phosphodiester metabolites of the anti-HIV nucleoside 2',3'-dideoxycytidine.
    Hao Z; Stowe EE; Ahluwalia G; Baker DC; Hebbler AK; Chisena C; Musser SM; Kelley JA; Perno CF; Johns DG
    Drug Metab Dispos; 1993; 21(4):738-44. PubMed ID: 7690699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro anti-hepatitis B virus activities of 5"-O-myristoyl analogue derivatives of 3"-fluoro-2",3"-dideoxythymidine (FLT) and 3"-azido-2",3"-dideoxythymidine (AZT).
    Parang K; Wiebe LI; Knaus EE; Huang JS; Tyrrell DL
    J Pharm Pharm Sci; 1998; 1(3):108-14. PubMed ID: 10948398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.